Somerville Kurt F Novo Nordisk A S Transaction History

Somerville Kurt F

$582 Million
Q2 2024

A detailed history of Somerville Kurt F transactions in Novo Nordisk A S stock. As of the latest transaction made, Somerville Kurt F holds 8,820 shares of NVO stock, worth $998,865. This represents 0.22% of its overall portfolio holdings.

Number of Shares

8,820

Previous 9,740 9.45%

Holding current value

$998,865

Previous $1.25 Million 0.64%

% of portfolio

0.22%

Previous 0.22%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	SELL	$122.71 - $146.91 $112,893 - $135,157	-920 Reduced 9.45%	8,820 $1.26 Million
Q1 2024 May 13, 2024	BUY	$102.11 - $135.92 $23,689 - $31,533	232 Added 2.44%	9,740 $1.25 Million
Q4 2023 Feb 13, 2024	SELL	$87.78 - $105.45 $70,224 - $84,360	-800 Reduced 7.76%	9,508 $983,000
Q3 2023 Nov 13, 2023	BUY	$90.94 - $199.54 $467,158 - $1.03 Million	5,137 Added 99.34%	10,308 $937,000
Q2 2023 Aug 11, 2023	SELL	$155.98 - $172.65 $1.09 Million - $1.2 Million	-6,978 Reduced 57.44%	5,171 $836,000
Q1 2023 May 10, 2023	SELL	$132.34 - $159.14 $20,248 - $24,348	-153 Reduced 1.24%	12,149 $1.93 Million
Q4 2022 Feb 09, 2023	SELL	$102.55 - $135.33 $13,331 - $17,592	-130 Reduced 1.05%	12,302 $1.66 Million
Q3 2022 Nov 08, 2022	SELL	$95.28 - $116.93 $45,734 - $56,126	-480 Reduced 3.72%	12,432 $1.24 Million
Q2 2022 Jul 19, 2022	SELL	$103.24 - $121.81 $241,581 - $285,035	-2,340 Reduced 15.34%	12,912 $1.44 Million
Q1 2022 May 17, 2022	SELL	$93.1 - $112.54 $13,965 - $16,881	-150 Reduced 0.97%	15,252 $1.69 Million
Q4 2021 Feb 08, 2022	SELL	$95.88 - $117.08 $170,954 - $208,753	-1,783 Reduced 10.38%	15,402 $1.73 Million
Q3 2021 Nov 10, 2021	SELL	$84.42 - $106.62 $12,072 - $15,246	-143 Reduced 0.83%	17,185 $1.65 Million
Q2 2021 Aug 09, 2021	SELL	$67.66 - $84.76 $135 - $169	-2 Reduced 0.01%	17,328 $1.45 Million
Q2 2020 Jul 28, 2020	SELL	$58.54 - $67.94 $292 - $339	-5 Reduced 0.03%	17,330 $1.14 Million
Q1 2020 May 07, 2020	SELL	$49.46 - $64.78 $22,998 - $30,122	-465 Reduced 2.61%	17,335 $1.04 Million
Q3 2019 Nov 06, 2019	SELL	$47.54 - $53.43 $11,885 - $13,357	-250 Reduced 1.39%	17,800 $920,000
Q2 2019 Jul 24, 2019	SELL	$46.79 - $52.47 $93,580 - $104,940	-2,000 Reduced 9.98%	18,050 $921,000
Q1 2019 May 01, 2019	SELL	$46.36 - $52.63 $11,543 - $13,104	-249 Reduced 1.23%	20,050 $1.05 Million
Q3 2018 Oct 15, 2018	BUY	$46.76 - $51.24 $57,748 - $63,281	1,235 Added 6.48%	20,299 $957,000
Q2 2018 Jul 30, 2018	SELL	$44.29 - $50.42 $2,923 - $3,327	-66 Reduced 0.35%	19,064 $880,000
Q1 2018 Apr 24, 2018	SELL	$48.49 - $58.14 $48,490 - $58,140	-1,000 Reduced 4.97%	19,130 $943,000
Q4 2017 Feb 02, 2018	SELL	$47.53 - $53.73 $262,603 - $296,858	-5,525 Reduced 21.54%	20,130 $1.08 Million
Q3 2017 Oct 26, 2017	BUY	$41.15 - $49.22 $1.06 Million - $1.26 Million	25,655	25,655 $1.24 Million

Others Institutions Holding NVO

# of Institutions

1,971

Shares Held

320M

Call Options Held

5.16M

Put Options Held

4.96M

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $256B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Somerville Kurt F, based on Form 13F filings with the SEC.

News

Stay updated on Somerville Kurt F with notifications on news.

Account

Somerville Kurt F Novo Nordisk A S Transaction History